ICD-10-CM code · FY2027
E08.351 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema
Header codeNot billable: use one of the 4 billable codes below
About E08.351
EvidencePulse™by 2 Minute Medicine®
Go deeper into diabetes.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E08.351
No notes of its own; the notes below apply from the codes above it.
7th character Required: add one of these as the 7th character, with X as a placeholder to fill six characters.
| Character | Meaning |
|---|---|
| 1 | right eye |
| 2 | left eye |
| 3 | bilateral |
| 9 | unspecified eye |
Also applies, from E08.35 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy
7th character
- One of the following 7th characters is to be assigned to codes in subcategory E08.35 to designate laterality of the disease:
Also applies, from E08 Diabetes mellitus due to underlying condition
Excludes1 Not coded here: never report these together with this code (use the code given instead).
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 1 diabetes mellitus (E10.-)
- type 2 diabetes mellitus (E11.-)
Code first Report the underlying condition's code before this one.
Use additional code Add a second code for the detail named here.
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Codes under E08.351 4
- E08.3511 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eyeBillable
- E08.3512 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eyeBillable
- E08.3513 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateralBillable
- E08.3519 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, unspecified eyeBillable
Related codes in E08.35
- E08.352 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the maculaHeader
- E08.353 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the maculaHeader
- E08.354 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachmentHeader
- E08.355 Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathyHeader
- E08.359 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edemaHeader
Latest research on diabetes
- Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes
- Telehealth yields modest improvements in diabetes outcomes
- Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes
- Smoking and prior acute pancreatitis attacks are risk factors for poor glycemic control in patients with post-chronic pancreatitis diabetes
- Weekly basal insulin efsitora effective for managing type 2 diabetes
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app